These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 21947321)
1. Hypoxia induces CD133 expression in human lung cancer cells by up-regulation of OCT3/4 and SOX2. Iida H; Suzuki M; Goitsuka R; Ueno H Int J Oncol; 2012 Jan; 40(1):71-9. PubMed ID: 21947321 [TBL] [Abstract][Full Text] [Related]
2. HIF1α and HIF2α regulate non-small-cell lung cancer dedifferentiation via expression of Sox2 and Oct4 under hypoxic conditions. Xiong S; Wang D; Tang Y; Lu S; Huang L; Wu Z; Lei S; Liang G; Yang D; Li D; Li Y Gene; 2023 May; 863():147288. PubMed ID: 36804853 [TBL] [Abstract][Full Text] [Related]
3. mTOR signal and hypoxia-inducible factor-1 alpha regulate CD133 expression in cancer cells. Matsumoto K; Arao T; Tanaka K; Kaneda H; Kudo K; Fujita Y; Tamura D; Aomatsu K; Tamura T; Yamada Y; Saijo N; Nishio K Cancer Res; 2009 Sep; 69(18):7160-4. PubMed ID: 19738050 [TBL] [Abstract][Full Text] [Related]
4. hypoxia-inducible factors activate CD133 promoter through ETS family transcription factors. Ohnishi S; Maehara O; Nakagawa K; Kameya A; Otaki K; Fujita H; Higashi R; Takagi K; Asaka M; Sakamoto N; Kobayashi M; Takeda H PLoS One; 2013; 8(6):e66255. PubMed ID: 23840432 [TBL] [Abstract][Full Text] [Related]
5. High expression of octamer-binding transcription factor 4A, prominin-1 and aldehyde dehydrogenase strongly indicates involvement in the initiation of lung adenocarcinoma resulting in shorter disease-free intervals. Cortes-Dericks L; Galetta D; Spaggiari L; Schmid RA; Karoubi G Eur J Cardiothorac Surg; 2012 Jun; 41(6):e173-81. PubMed ID: 22529186 [TBL] [Abstract][Full Text] [Related]
6. Hypoxia increases gefitinib-resistant lung cancer stem cells through the activation of insulin-like growth factor 1 receptor. Murakami A; Takahashi F; Nurwidya F; Kobayashi I; Minakata K; Hashimoto M; Nara T; Kato M; Tajima K; Shimada N; Iwakami S; Moriyama M; Moriyama H; Koizumi F; Takahashi K PLoS One; 2014; 9(1):e86459. PubMed ID: 24489728 [TBL] [Abstract][Full Text] [Related]
8. CD133+ subpopulation of the HT1080 human fibrosarcoma cell line exhibits cancer stem-like characteristics. Feng BH; Liu AG; Gu WG; Deng L; Cheng XG; Tong TJ; Zhang HZ Oncol Rep; 2013 Aug; 30(2):815-23. PubMed ID: 23708735 [TBL] [Abstract][Full Text] [Related]
9. Profiling gene promoter occupancy of Sox2 in two phenotypically distinct breast cancer cell subsets using chromatin immunoprecipitation and genome-wide promoter microarrays. Jung K; Wang P; Gupta N; Gopal K; Wu F; Ye X; Alshareef A; Bigras G; McMullen TP; Abdulkarim BS; Lai R Breast Cancer Res; 2014 Nov; 16(6):470. PubMed ID: 25380620 [TBL] [Abstract][Full Text] [Related]
10. Correlation of CD133, OCT4, and SOX2 in rectal cancer and their association with distant recurrence after chemoradiotherapy. Saigusa S; Tanaka K; Toiyama Y; Yokoe T; Okugawa Y; Ioue Y; Miki C; Kusunoki M Ann Surg Oncol; 2009 Dec; 16(12):3488-98. PubMed ID: 19657699 [TBL] [Abstract][Full Text] [Related]
11. Hypoxia promotes radioresistance of CD133-positive Hep-2 human laryngeal squamous carcinoma cells in vitro. Wang M; Li X; Qu Y; Xu O; Sun Q Int J Oncol; 2013 Jul; 43(1):131-40. PubMed ID: 23652853 [TBL] [Abstract][Full Text] [Related]
12. Analysis of an alternative human CD133 promoter reveals the implication of Ras/ERK pathway in tumor stem-like hallmarks. Tabu K; Kimura T; Sasai K; Wang L; Bizen N; Nishihara H; Taga T; Tanaka S Mol Cancer; 2010 Feb; 9():39. PubMed ID: 20167130 [TBL] [Abstract][Full Text] [Related]
13. Hypoxia promotes stem-like properties of laryngeal cancer cell lines by increasing the CD133+ stem cell fraction. Wu CP; Du HD; Gong HL; Li DW; Tao L; Tian J; Zhou L Int J Oncol; 2014 May; 44(5):1652-60. PubMed ID: 24573690 [TBL] [Abstract][Full Text] [Related]
14. Inflammation-related DNA damage and expression of CD133 and Oct3/4 in cholangiocarcinoma patients with poor prognosis. Thanan R; Pairojkul C; Pinlaor S; Khuntikeo N; Wongkham C; Sripa B; Ma N; Vaeteewoottacharn K; Furukawa A; Kobayashi H; Hiraku Y; Oikawa S; Kawanishi S; Yongvanit P; Murata M Free Radic Biol Med; 2013 Dec; 65():1464-1472. PubMed ID: 23917144 [TBL] [Abstract][Full Text] [Related]
15. HIF induces human embryonic stem cell markers in cancer cells. Mathieu J; Zhang Z; Zhou W; Wang AJ; Heddleston JM; Pinna CM; Hubaud A; Stadler B; Choi M; Bar M; Tewari M; Liu A; Vessella R; Rostomily R; Born D; Horwitz M; Ware C; Blau CA; Cleary MA; Rich JN; Ruohola-Baker H Cancer Res; 2011 Jul; 71(13):4640-52. PubMed ID: 21712410 [TBL] [Abstract][Full Text] [Related]
16. Hypoxia induces tumor aggressiveness and the expansion of CD133-positive cells in a hypoxia-inducible factor-1α-dependent manner in pancreatic cancer cells. Hashimoto O; Shimizu K; Semba S; Chiba S; Ku Y; Yokozaki H; Hori Y Pathobiology; 2011; 78(4):181-92. PubMed ID: 21778785 [TBL] [Abstract][Full Text] [Related]
17. Reciprocal transcriptional regulation of Pou5f1 and Sox2 via the Oct4/Sox2 complex in embryonic stem cells. Chew JL; Loh YH; Zhang W; Chen X; Tam WL; Yeap LS; Li P; Ang YS; Lim B; Robson P; Ng HH Mol Cell Biol; 2005 Jul; 25(14):6031-46. PubMed ID: 15988017 [TBL] [Abstract][Full Text] [Related]
18. Hypoxia modulates the undifferentiated phenotype of human renal inner medullary CD133+ progenitors through Oct4/miR-145 balance. Bussolati B; Moggio A; Collino F; Aghemo G; D'Armento G; Grange C; Camussi G Am J Physiol Renal Physiol; 2012 Jan; 302(1):F116-28. PubMed ID: 21900452 [TBL] [Abstract][Full Text] [Related]
19. CD133 expression in renal cell carcinoma (RCC) is correlated with nuclear hypoxia-inducing factor 1α (HIF-1α). Sun C; Song H; Zhang H; Hou C; Zhai T; Huang L; Zhang L J Cancer Res Clin Oncol; 2012 Oct; 138(10):1619-24. PubMed ID: 22614155 [TBL] [Abstract][Full Text] [Related]
20. Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells. Masui S; Nakatake Y; Toyooka Y; Shimosato D; Yagi R; Takahashi K; Okochi H; Okuda A; Matoba R; Sharov AA; Ko MS; Niwa H Nat Cell Biol; 2007 Jun; 9(6):625-35. PubMed ID: 17515932 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]